Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alan Go and Stacy Sterling.
Alan Go
Connection Strength
7.087
Stacy Sterling
  1. Human Immunodeficiency Virus Infection and Variation in Heart Failure Risk by Age, Sex, and Ethnicity: The HIV HEART Study. Mayo Clin Proc. 2021 Dec 11.
    View in: PubMed
    Score: 0.831
  2. Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia. J Am Heart Assoc. 2018 Jul 07; 7(14).
    View in: PubMed
    Score: 0.655
  3. Cardiovascular Disease Consequences of CKD. Semin Nephrol. 2016 07; 36(4):293-304.
    View in: PubMed
    Score: 0.570
  4. Timing of AKI after urgent percutaneous coronary intervention and clinical outcomes: a high-dimensional propensity score analysis. BMC Nephrol. 2021 Sep 06; 22(1):300.
    View in: PubMed
    Score: 0.408
  5. Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study. J Am Soc Nephrol. 2021 Sep; 32(9):2303-2314.
    View in: PubMed
    Score: 0.402
  6. Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events. Clin J Am Soc Nephrol. 2018 Jun 07; 13(6):833-841.
    View in: PubMed
    Score: 0.324
  7. Stroke prevention in atrial fibrillation: another step sideways. Lancet. 2008 Jan 26; 371(9609):278-80.
    View in: PubMed
    Score: 0.318
  8. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23.
    View in: PubMed
    Score: 0.283
  9. Antithrombotic therapy for stroke prevention in atrial fibrillation. Prog Cardiovasc Dis. 2005 Sep-Oct; 48(2):108-24.
    View in: PubMed
    Score: 0.269
  10. Anticoagulants for stroke prevention in atrial fibrillation: what is the right rate and where do we go from here? Nat Clin Pract Cardiovasc Med. 2005 May; 2(5):226-7.
    View in: PubMed
    Score: 0.263
  11. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005 Mar-Apr; 14(2):56-61.
    View in: PubMed
    Score: 0.260
  12. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003 Nov 26; 290(20):2685-92.
    View in: PubMed
    Score: 0.238
  13. Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Thromb Thrombolysis. 2003 Feb; 15(1):41-6.
    View in: PubMed
    Score: 0.225
  14. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol. 2011 Oct 04; 58(15):1600-7.
    View in: PubMed
    Score: 0.205
  15. COVID-19 and Risk of VTE in Ethnically Diverse Populations. Chest. 2021 Jul 19.
    View in: PubMed
    Score: 0.202
  16. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.180
  17. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med. 2008 Dec 08; 168(22):2415-21.
    View in: PubMed
    Score: 0.169
  18. Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus. BMC Nephrol. 2018 06 22; 19(1):146.
    View in: PubMed
    Score: 0.163
  19. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.154
  20. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
    View in: PubMed
    Score: 0.152
  21. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.146
  22. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens. 2006 May; 15(3):296-302.
    View in: PubMed
    Score: 0.141
  23. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006 Feb 21; 144(4):229-38.
    View in: PubMed
    Score: 0.139
  24. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 09 23; 351(13):1296-305.
    View in: PubMed
    Score: 0.126
  25. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010 Aug 27; 11:22.
    View in: PubMed
    Score: 0.095
  26. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009 Mar 17; 119(10):1363-9.
    View in: PubMed
    Score: 0.086
  27. The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008 Nov; 1(2):138-47.
    View in: PubMed
    Score: 0.084

© 2024 Kaiser Permanente